Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET

Oral Oncology

Volumn 41, Issue 4, 2005, Pages 390-395

  Nam, Soon Yuhl ^a   Lee, Sang Wook ^a   Im, Ki Chun ^a   Kim, Jae Seung ^a   Kim, Sang Yoon ^a   Choi, Seung Ho ^a   Ryu, Jin Sook ^a   Moon, Dae Hyuk ^a   Oh, Seung Joon ^a   Yi, Byong Yong ^a   Kim, Jong Hoon ^a   Ahn, Seung Do ^a   Shin, Seong Soo ^a   Kim, Sung Bae ^a   Choi, Eun Kyung ^a   Lee, Bong Jae ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

FDG PET; Head and neck; Radiotherapy; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 20144385197     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.10.005     Document Type: Article

References (36)

1. A.D. Bronstein, D.A. Nyberg, A.N. Schwartz, W.P. Shuman, and B.R. Griffin Soft-tissue changes after head and neck radiation: CT findings Am J Neuroradiol 10 1989 171 175
2. H.S. Glazer, J.H. Niemeyer, D.M. Balfe, R.E. Hayden, B. Emami, and V.R. Devineni Neck neoplasms: MR imaging. II. Posttreatment evaluation Radiology 160 1986 349 354
3. S.M. Larson, P.L. Weiden, Z. Grunbaum, H.G. Kaplan, J.S. Rasey, and M.M. Graham Positron imaging feasibility studies. II. Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication J Nucl Med 22 1981 875 879
4. R.A. Hawkins, C. Hoh, M. Dahlbom, Y. Choi, J. Glaspy, and N. Tse PET cancer evaluations with FDG J Nucl Med 32 1991 1555 1558
5. R.L. Wahl, G.D. Hutchins, D.J. Buchsbaum, M. Liebert, H.B. Grossman, and S. Fisher 18F-2-Deoxy-2-fluoro-d-glucose uptake into human tumor xenografts: feasibility studies for cancer imaging with positron-emission tomography Cancer 67 1991 1544 1550
6. E.R. Sigurdson, and A.M. Cohen Commentary on the applications of PET in clinical oncology J Nucl Med 32 1991 649 650
7. M. Lapela, R. Grenman, T. Kurki, H. Joensuu, S. Leskinen, and P. Lindholm Head and neck cancer: detection of recurrence with PET and 2[F-18]fluoro-2- dexoy-d-glucose Radiology 197 1995 205 211
8. U. Haberkorn, L.G. Strauss, A. Dimitrakopoulou, E. Seiffert, F. Oberdorfer, and S. Ziegler Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy J Nucl Med 34 1993 12 17
9. Y. Kitagawa, N. Sadato, H. Azuma, T. Ogasawara, M. Yoshida, and Y. Ishii FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms J Nucl Med 40 1999 1132 1137
10. V.J. Lowe, F.R. Dunphy, M. Varvares, H. Kim, M. Wittry, and C.H. Dunphy Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography Head Neck 19 1997 666 674
11. K.M. Greven, D.W. Williams 3rd, J.W. Keyes Jr, W.F. McGuirt, N.E. Watson Jr, and M.E. Randall Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation Cancer 74 1994 1355 1359
12. Y. Kitagawa, N. Sadato, H. Azuma, T. Ogasawara, M. Yoshida, and Y. Ishii FDG-PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms J Nucl Med 40 1999 1132 1137
13. G.W. Goerres, D.T. Schmid, F. Bandhauer, P.U. Huguenin, G.K. von Schulthess, and S. Schmid Positron emission tomography in the early follow-up of advanced head and neck cancer Arch Otolaryngol Head Neck Surg 130 2004 105 109
14. J.E. Terrell, S.G. Fisher, and G.T. Wolf Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer study group Arch Otolaryngol Head Neck Surg 124 1998 964 971
15. L. Chaiken, S. Rege, C. Hoh, Y. Choi, B. Jabour, and G. Juillard Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy Int J Radiat Oncol Biol Phys 27 1993 455 464
16. Y. Anzai, W.R. Carroll, D.J. Quint, C.R. Bradford, S. Minoshima, and G.T. Wolf Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-d-glucose PET and MR imaging diagnoses Radiology 200 1996 135 141
17. J.W. Bailet, J.A. Sercarz, E. Abemayor, Y. Anzai, R.B. Lufkin, and C.K. Hoh The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients Laryngoscope 105 1995 135 139
18. J. Nuutinen, S. Jyrkkio, P. Lehikoinen, P. Lindholm, and H. Minn Evaluation of early response to radiotherapy in head and neck cancer measured with [11-C] methionine-positron emission tomography Radiother Oncol 52 1999 225 232
19. T. Jansson, J.E. Westlin, H. Ahlstrom, A. Lilja, B. Langstrom, and J. Bergh Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation J Clin Oncol 13 1995 1470 1477
20. M. Schelling, N. Avril, W. Nahrig, W. Kuhn, W. Romer, and D. Sattler Positron emission tomography using 18F fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J Cin Oncol 18 2000 1689 1695
21. M. Schulte, D. Brecht-Krauss, M. Werner, E. Hartwig, M.R. Sarkar, and P. Keppler Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET J Nucl Med 40 1999 1637 1643
22. W. Romer, A.-R. Hanauske, S. Ziegler, R. Thodtmann, W. Weber, and C. Fuchs Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose Blood 91 1998 4464 4471
23. C.S. Brock, H. Young, S.M. O'Reilly, J. Matthews, S. Osman, and H. Evans Early evaluation of tumour metabolic response using [18F]-fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas Br J Cancer 82 2000 608 615
24. N.J. Fischbein, O.S. AAssar, G.R. Caputo, M.J. Kaplan, M.I. Singer, and D.C. Price Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck Am J Neuroradiol 19 1998 1189 1196
25. C.H. Terhaard, V. Bongers, P.P. van Rijk, and G.J. Hordijk F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer Head Neck 23 2001 933 941
26. M. Lonneux, G. Lawson, C. Ide, R. Bausart, M. Remacle, and S. Pauwels Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient Laryngoscope 110 2000 1493 1497
27. L.A. Farber, F. Benard, M. Machtay, R.J. Smith, R.S. Weber, and G.S. Weinstein Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography Laryngoscope 109 1999 970 975
28. M. Lapela, A. Eigtved, S. Jyrkkio, R. Grenman, T. Kurki, and P. Lindholm Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer Eur J Cancer 36 2000 858 867
29. K.M. Greven, D.W. Williams 3rd, J.W. Keyes Jr, W.F. McGuirt, N.E. Watson Jr, and L.D. Case Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer Cancer J Sci Am 3 1997 353 357
30. C.A. Haenggeli, P. Dulguerov, D. Slosman, M. Becker, P. Bang, and A. Allal Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma Schweiz Med Wochenschr Suppl 116 2000 8S 11S
31. K.M. Greven, D.W. Williams 3rd, W.F. McGuirt Sr, B.A. Harkness, R.B. D'Agostino Jr, and J.W. Keyes Jr Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer Head Neck 23 2001 942 946
32. M.H. Tsai, Y.C. Shiau, C.H. Kao, Y.Y. Shen, C.C. Lin, and C.C. Lee Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy J Cancer Res Clin Oncol 128 2002 279 282
33. C.H. Kao, S.C. Tsai, J.J. Wang, Y.J. Ho, R.F. Yen, and S.T. Ho Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy Cancer 92 2001 434 439
34. N. Mitsuhashi, K. Hayakawa, M. Hasegawa, M. Furuta, S. Katano, and H. Sakurai Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor Anticancer Res 18 1998 2827 2832
35. K.M. Greven, D.W. Williams 3rd, J.W. Keyes Jr, W.F. McGuirt, B.A. Harkness, and N.E. Watson Jr Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer Int J Radiat Oncol Biol Phys 29 1994 841 845
36. T. Eichhorn, H.G. Schroeder, H. Glanz, and W.B. Schwerk Histologically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases Laryngol Rhinol Otol 66 1987 266 274